Home > Publications database > CAF Specific Expression of Podoplanin May Be Dispensable for the Malignancy of Malignant Melanoma > print

001     294541
005     20250117092956.0
024 7 _ |a 10.1002/mc.23841
|2 doi
024 7 _ |a 0899-1987
|2 ISSN
024 7 _ |a 1098-2744
|2 ISSN
037 _ _ |a DKFZ-2024-02316
082 _ _ |a 610
100 1 _ |a Tauch, Saskia
|0 P:(DE-He78)f112986f685bcedfb852b4c86803bece
|b 0
|e First author
|u dkfz
245 _ _ |a CAF Specific Expression of Podoplanin May Be Dispensable for the Malignancy of Malignant Melanoma
260 _ _ |a New York, NY
|c 2025
|b Wiley Interscience
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1737102524_3882
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:A100#LA:A100# / DKFZ-ZMBH Alliance / BRIEF COMMUNICATION / 2025 Feb;64(2):215-220
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Kast, Bettina
|0 P:(DE-He78)417337e7f94f6e1325a168191cbdc4f1
|b 1
|u dkfz
700 1 _ |a Lohr, Sabrina
|0 P:(DE-He78)d7efff917864e0e86459893cf0e83a99
|b 2
|u dkfz
700 1 _ |a Kemm, Lowis
|0 P:(DE-He78)5a57decdcc5b38be71eded808a50db33
|b 3
700 1 _ |a Sator-Schmitt, Melanie
|0 P:(DE-He78)2119821cf3458781f06157c7aeecba8b
|b 4
|u dkfz
700 1 _ |a Gengenbacher, Nicolas
|0 P:(DE-He78)d2851af71b2aced0c34d8c71329c3bc5
|b 5
700 1 _ |a Augustin, Hellmut G.
|0 P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b
|b 6
|u dkfz
700 1 _ |a Angel, Peter
|0 P:(DE-He78)f4f068e71e0d87bf0ad51e6214ab84e9
|b 7
|e Last author
|u dkfz
773 _ _ |a 10.1002/mc.23841
|g p. mc.23841
|0 PERI:(DE-600)2001984-1
|n 2
|p 215-220
|t Molecular carcinogenesis
|v 64
|y 2025
|x 0899-1987
909 C O |p VDB
|o oai:inrepo02.dkfz.de:294541
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)f112986f685bcedfb852b4c86803bece
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)417337e7f94f6e1325a168191cbdc4f1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)d7efff917864e0e86459893cf0e83a99
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)5a57decdcc5b38be71eded808a50db33
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)2119821cf3458781f06157c7aeecba8b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)d2851af71b2aced0c34d8c71329c3bc5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)2e92d0ae281932fc7347d819fec36b0b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)f4f068e71e0d87bf0ad51e6214ab84e9
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2024
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-08-23
|w ger
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2023-08-23
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-23
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-23
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MOL CARCINOGEN : 2022
|d 2023-08-23
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-08-23
920 2 _ |0 I:(DE-He78)A100-20160331
|k A100
|l A100 Signaltransduktion/ Wachstumskontrolle
|x 0
920 1 _ |0 I:(DE-He78)A100-20160331
|k A100
|l A100 Signaltransduktion/ Wachstumskontrolle
|x 0
920 1 _ |0 I:(DE-He78)A010-20160331
|k A010
|l A010 Stammzellen und Krebs
|x 1
920 1 _ |0 I:(DE-He78)A190-20160331
|k A190
|l A190 Vaskuläre Onkologie und Metastasierung
|x 2
920 0 _ |0 I:(DE-He78)A100-20160331
|k A100
|l A100 Signaltransduktion/ Wachstumskontrolle
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A100-20160331
980 _ _ |a I:(DE-He78)A010-20160331
980 _ _ |a I:(DE-He78)A190-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21